Ampio opens new headquarters, manufacturing and research facility in Englewood

Ampio opens new headquarters, manufacturing and research facility in Englewood

ENGLEWOOD - Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE) today announced the opening of its new headquarters, manufacturing and research facility in Englewood. The facility is located at... Read More

By: InnovatioNews Wednesday July 23, 2014 0 comments Tags: Ampion, Englewood, Michael Macaluso

Ampio breaks ground on new manufacturing facility in Denver Tech Center

Ampio breaks ground on new manufacturing facility in Denver Tech Center

GREENWOOD VILLAGE - Ampio Pharmaceuticals Inc. (NYSE MKT: AMPE) announced it has broken ground on a new state-of-the-art manufacturing facility for its lead drug candidate, Ampion, for the... Read More

By: InnovatioNews Thursday January 16, 2014 0 comments Tags: Ampion, April Giles, Greenwood Village, Ken Lund, Michael Macaluso

Ampio to transfer stock trade from Nasdaq to NYSE MKT on June 17

Ampio to transfer stock trade from Nasdaq to NYSE MKT on June 17

GREENWOOD VILLAGE - Ampio Pharmaceuticals Inc. (Nasdaq: AMPE) announced it has received authorization from the NYSE Euronext (NYSE: MKT) to transfer its listing from the Nasdaq Capital Market... Read More

By: Steve Monday June 10, 2013 0 comments Tags: AMPE, Greenwood Village, Michael Macaluso, Scott Cutler

Ampio Pharmaceuticals seeks to end eye injections with oral therapy for diabetic macular edema

Ampio Pharmaceuticals seeks to end eye injections with oral therapy for diabetic macular edema

GREENWOOD VILLAGE - Ampio Pharmaceuticals Inc. (Nasdaq: AMPE) announced the oral dosing of its first patient in a 505(b)(2) clinical trial of its investigational drug, Optina, to treat diabetic... Read More

By: Steve Friday March 1, 2013 0 comments Tags: Greenwood Village, Michael Macaluso, Optina